Noema Pharma Ag
Clinical trials sponsored by Noema Pharma Ag, explained in plain language.
-
New pill aims to quiet tourette tics in landmark trial
Symptom relief OngoingThis study tests an experimental drug called gemlapodect to see if it can safely reduce tics in people with Tourette syndrome. About 164 adults and teens with moderate to severe tics will take the drug or a placebo for 12 weeks. The main goal is to measure changes in tic severity…
Phase: PHASE2 • Sponsor: Noema Pharma AG • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New pill could ease the 'Suicide Disease' for patients failed by current meds
Symptom relief OngoingThis study tests a daily drug called basimglurant for adults with trigeminal neuralgia, a condition causing severe facial pain often called the 'suicide disease.' The trial includes 166 people who still have pain despite current treatments. After an 8-week run-in on the drug, par…
Phase: PHASE2, PHASE3 • Sponsor: Noema Pharma AG • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC